Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

457 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Anidulafungin: a new echinocandin with a novel profile.
Vazquez JA. Vazquez JA. Clin Ther. 2005 Jun;27(6):657-73. doi: 10.1016/j.clinthera.2005.06.010. Clin Ther. 2005. PMID: 16117974 Review.
Vaginitis due to Candida krusei: epidemiology, clinical aspects, and therapy.
Singh S, Sobel JD, Bhargava P, Boikov D, Vazquez JA. Singh S, et al. Clin Infect Dis. 2002 Nov 1;35(9):1066-70. doi: 10.1086/343826. Epub 2002 Oct 10. Clin Infect Dis. 2002. PMID: 12384840
Efficacy of alcohol-based and alcohol-free melaleuca oral solution for the treatment of fluconazole-refractory oropharyngeal candidiasis in patients with AIDS.
Vazquez JA, Zawawi AA. Vazquez JA, et al. HIV Clin Trials. 2002 Sep-Oct;3(5):379-85. doi: 10.1310/99dy-8q52-306a-v0aj. HIV Clin Trials. 2002. PMID: 12407487 Clinical Trial.
Mucosal candidiasis.
Vazquez JA, Sobel JD. Vazquez JA, et al. Infect Dis Clin North Am. 2002 Dec;16(4):793-820, v. doi: 10.1016/s0891-5520(02)00042-9. Infect Dis Clin North Am. 2002. PMID: 12512182 Review.
A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects.
Rex JH, Pappas PG, Karchmer AW, Sobel J, Edwards JE, Hadley S, Brass C, Vazquez JA, Chapman SW, Horowitz HW, Zervos M, McKinsey D, Lee J, Babinchak T, Bradsher RW, Cleary JD, Cohen DM, Danziger L, Goldman M, Goodman J, Hilton E, Hyslop NE, Kett DH, Lutz J, Rubin RH, Scheld WM, Schuster M, Simmons B, Stein DK, Washburn RG, Mautner L, Chu TC, Panzer H, Rosenstein RB, Booth J; National Institute of Allergy and Infectious Diseases Mycoses Study Group. Rex JH, et al. Clin Infect Dis. 2003 May 15;36(10):1221-8. doi: 10.1086/374850. Epub 2003 May 8. Clin Infect Dis. 2003. PMID: 12746765 Clinical Trial.
Phase 2, randomized, dose-ranging study evaluating the safety and efficacy of anidulafungin in invasive candidiasis and candidemia.
Krause DS, Reinhardt J, Vazquez JA, Reboli A, Goldstein BP, Wible M, Henkel T; Anidulafungin Invasive Candidiasis Study Group. Krause DS, et al. Antimicrob Agents Chemother. 2004 Jun;48(6):2021-4. doi: 10.1128/AAC.48.6.2021-2024.2004. Antimicrob Agents Chemother. 2004. PMID: 15155194 Free PMC article. Clinical Trial.
Multiechinocandin- and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis.
Moudgal V, Little T, Boikov D, Vazquez JA. Moudgal V, et al. Antimicrob Agents Chemother. 2005 Feb;49(2):767-9. doi: 10.1128/AAC.49.2.767-769.2005. Antimicrob Agents Chemother. 2005. PMID: 15673762 Free PMC article.
Efficacy of caspofungin against invasive Candida or invasive Aspergillus infections in neutropenic patients.
Betts R, Glasmacher A, Maertens J, Maschmeyer G, Vazquez JA, Teppler H, Taylor A, Lupinacci R, Sable C, Kartsonis N. Betts R, et al. Cancer. 2006 Jan 15;106(2):466-73. doi: 10.1002/cncr.21615. Cancer. 2006. PMID: 16353208 Review.
457 results
Jump to page
Feedback